- Home
- CNTA vs ERO Comparison
CNTA vs ERO Comparison
Compare CNTA & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTA | ERO |
|---|---|---|
| Founded | 2020 | 2016 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 3.2B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CNTA | ERO |
|---|---|---|
| Price | $39.58 | $25.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $43.17 | $36.50 |
| AVG Volume (30 Days) | ★ 2.5M | 936.7K |
| Earning Date | 05-13-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,000,000.00 | N/A |
| Revenue This Year | N/A | $51.94 |
| Revenue Next Year | N/A | $2.43 |
| P/E Ratio | ★ N/A | $22.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.95 | $12.56 |
| 52 Week High | $40.26 | $39.80 |
Technical Indicators
Market Signals| Indicator | CNTA | ERO |
|---|---|---|
| Relative Strength Index (RSI) | 73.62 | 35.84 |
| Support Level | $39.16 | $23.01 |
| Resistance Level | $40.26 | $26.77 |
| Average True Range (ATR) | 0.17 | 1.22 |
| MACD | -0.48 | -0.39 |
| Stochastic Oscillator | 76.27 | 0.00 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About ERO Ero Copper Corp.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.